Thomas Eastling - Apr 16, 2025 Form 4 Insider Report for GYRE THERAPEUTICS, INC. (GYRE)

Role
Director
Signature
/s/ Ruoyu Chen, as attorney-in-fact for Thomas Eastling
Stock symbol
GYRE
Transactions as of
Apr 16, 2025
Transactions value $
$103,950
Form type
4
Date filed
4/18/2025, 05:27 PM
Previous filing
Aug 16, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GYRE Common Stock Options Exercise $104K +15K $6.93 15K Apr 16, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GYRE Stock Option (Right to Buy) Options Exercise $0 -15K -4.77% $0.00 300K Apr 16, 2025 Common Stock 15K $6.93 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options are vested in full.